Dataset
Nalidixic acid, 389-08-2[5]
Chemical Information
| InChI | InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17) |
|---|---|
| SMILES | CCN1C=C(C(=O)O)C(=O)C2=C1N=C(C)C=C2 |
| InChI Key | MHWLWQUZZRMNGJ-UHFFFAOYSA-N |
| Molecular Formula | C12H12N2O3 |
| Exact Mass | 232.230 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | 10.57992/nmrxiv.p12.s74.d432 |
| License URL | https://creativecommons.org/licenses/by/4.0/legalcode |
| Source | https://nmrxiv.org/D432 |
| Version | |
| Author | Mohr J, Porwal D, Chatterjee I, Oestreich M. |
| Maintainer | |
| Language | english |
| MetadataPublished | 2022-11-09T09:57:24.000000Z |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | heteronuclear single quantum coherence |
| Measurement Variables |
|
| Data-Source Molecule ID | Data-Source |
|---|---|
| MCULE-6808033849 | Mcule |
| 20123603 | NMRShiftDB |
| SCHEMBL21736 | SureChEMBL |
| HMDB0014917 | Human Metabolome Database |
| CB1194283 | ChemicalBook |
| 114048 | Brenda |
| 2148 | Brenda |
| Nalidixic-acid(NegGram) | Selleck |
| PA164746384 | PharmGKB |
| LSM-5590 | LINCS |
| 3B91HWA56M | FDA SRS |
| PD001597 | ProbesDrugs |
| 4421 | PubChem |
| 389-08-2 | ACToR |
| 14773844 | PubChem: Thomson Pharma |
| 529362 | eMolecules |
| DB00779 | DrugBank |
| C05079 | KEGG Ligand |
| CHEMBL5 | ChEMBL |
| SAM002554914 | NIH Clinical Collection |
| 100147 | ChEBI |
| NIX | PDBe |
| NALIDIXATE | rxnorm |
| NALIDIXIC ACID | rxnorm |
| NALIDIXATE SODIUM | clinicaltrials |
| NALIDIXIC ACID | clinicaltrials |
| NEGGRAM | clinicaltrials |
| HY-B0398 | MedChemExpress |
| DTXSID3020912 | EPA CompTox Dashboard |
| 1875 | DrugCentral |
| ZINC000000057421 | ZINC |
| J2.039G | Nikkaji |
| NALIDX | CCDC |
| 21691 | BindingDB |
| The data in this table is sourced from UniChem at EBI. | |